MedTrace Logo

Study on Patterns of Care in Mild Asthmatic Patients

NCT04598555 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 981

Last updated 2022-09-27

No results posted yet for this study

Summary

The PRIME study is an observational, Real World Evidence study designed to collect the type of treatments that are currently prescribed to patients with mild asthma and to collect relevant clinical data that could reflect the control of the disease over a 6-month observational period according to the standard clinical practice.

Conditions

Sponsors & Collaborators

  • Chiesi Farmaceutici S.p.A.

    lead INDUSTRY

Principal Investigators

  • Eva Topole, Dr · CHIESI Clinical Program Leader

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-25
Primary Completion
2022-09-02
Completion
2022-09-02

Countries

  • Germany
  • Italy
  • Poland
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04598555 on ClinicalTrials.gov